What are the role of prostaglandings used in glaucoma Mbbs 2nd year based answer
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Searching PubMed
prostaglandin analogue glaucoma intraocular pressure
These confirm the standard textbook picture (efficacy/safety network meta-analysis, adherence review) - nothing that contradicts the basic pharmacology below, so I'll note them briefly at the end.
Prostaglandin Analogues in Glaucoma - MBBS Level
Drugs in this class
Latanoprost, bimatoprost, travoprost, and tafluprost - all synthetic PGF2α analogues. Latanoprost was the first developed and remains the most widely prescribed anti-glaucoma drug worldwide.
Mechanism of action
- They act as agonists at the FP receptor (prostaglandin F receptor) present in the ciliary muscle and sclera.
- Latanoprost itself is a prodrug (isopropyl ester) that gets hydrolyzed by corneal esterases into its active acid form.
- FP receptor activation relaxes the ciliary muscle and remodels the extracellular matrix (via matrix metalloproteinases) in the ciliary body/sclera, which increases uveoscleral outflow of aqueous humor.
- Unlike beta-blockers or carbonic anhydrase inhibitors, they do not significantly reduce aqueous humor production - they work almost entirely by improving the outflow pathway.
- Net effect: significant, sustained reduction in intraocular pressure (IOP).
Clinical use
- First-line therapy for primary open-angle glaucoma and ocular hypertension.
- Applied as a topical ophthalmic solution, once daily (usually at bedtime, since IOP-lowering effect is diurnally more pronounced then).
- Comparable to or more effective than timolol (a beta-blocker) in lowering IOP, with the advantage of once-daily dosing improving compliance.
Adverse effects (important for exams)
- Increased brown pigmentation of the iris (due to increased melanin synthesis in melanocytes, not proliferation) - can be permanent and is more noticeable in mixed-colored irises (blue-brown).
- Eyelash changes: increased length, thickness, and number of eyelashes (hypertrichosis) - this side effect is actually exploited commercially (bimatoprost is FDA-approved for eyelash hypotrichosis).
- Periorbital skin darkening (reversible on stopping).
- Conjunctival hyperemia, ocular irritation/foreign body sensation, blurred vision.
- Rarely, cystoid macular edema (caution in aphakic/pseudophakic patients) and reactivation of herpetic keratitis.
Quick comparison table
| Feature | Prostaglandin analogues |
|---|---|
| Receptor | FP receptor agonist |
| Mechanism | ↑ Uveoscleral outflow |
| Effect on aqueous production | Minimal |
| Dosing | Once daily (evening) |
| First-line for | Open-angle glaucoma |
| Key side effect | Iris/eyelash pigmentation changes |
Sources: Katzung's Basic and Clinical Pharmacology, 16th ed., p. 533; Goodman & Gilman's Pharmacological Basis of Therapeutics; Lippincott Illustrated Reviews - Pharmacology, p. 1342.
A 2025 systematic review/meta-analysis (PMID: 40861241) and an adherence review (PMID: 40113120) reaffirm that prostaglandin analogues remain among the most effective and best-tolerated first-line IOP-lowering agents, consistent with the textbook teaching above - no major contradiction to note.
Make a crisp answer to score full marks
Prostaglandin Analogues in Glaucoma
Drugs: Latanoprost, Bimatoprost, Travoprost, Tafluprost (PGF2α analogues)
Mechanism of Action:
- Agonists at FP receptor on ciliary muscle/sclera
- ↑ Uveoscleral outflow of aqueous humor (remodel ciliary muscle ECM via MMPs)
- Little/no effect on aqueous humor production
Result: ↓ Intraocular pressure (IOP)
Use: First-line drug for primary open-angle glaucoma and ocular hypertension. Given as eye drops, once daily (at bedtime).
Advantages:
- Most potent IOP-lowering class; equal or superior to timolol
- Once-daily dosing → better compliance
- Few systemic side effects (minimal systemic absorption)
Adverse Effects (exam favorite):
- ↑ Brown pigmentation of iris (permanent)
- Eyelash hypertrichosis (↑ length, thickness, number) - bimatoprost licensed for this
- Periorbital skin darkening (reversible)
- Conjunctival hyperemia, ocular irritation
- Rarely: cystoid macular edema, herpetic keratitis reactivation
One-line summary: Prostaglandin analogues (e.g., latanoprost) are FP receptor agonists that lower IOP mainly by increasing uveoscleral outflow, used once daily as first-line therapy in open-angle glaucoma, with iris/eyelash pigmentation as the characteristic side effect.
This is a shared conversation. Sign in to Orris to start your own chat.